QIAGEN (QGEN)
(Delayed Data from NYSE)
$46.27 USD
-0.45 (-0.96%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $46.30 +0.03 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Balance Sheet
Fiscal Year End for QIAGEN NV falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,058 | 1,418 | 1,065 | 729 | 867 |
Receivables | 382 | 324 | 362 | 440 | 427 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 398 | 358 | 328 | 291 | 171 |
Other Current Assets | 310 | 294 | 355 | 207 | 105 |
Total Current Assets | 2,148 | 2,394 | 2,110 | 1,667 | 1,570 |
Net Property & Equipment | 765 | 662 | 638 | 559 | 455 |
Investments & Advances | 3 | 131 | 190 | 379 | 192 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 73 | 55 | 57 |
Intangibles | 3,003 | 2,897 | 2,978 | 3,090 | 2,773 |
Deposits & Other Assets | 197 | 203 | 158 | 162 | 188 |
Total Assets | 6,115 | 6,288 | 6,147 | 5,913 | 5,236 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 84 | 99 | 101 | 118 | 85 |
Current Portion Long-Term Debt | 588 | 390 | 848 | 43 | 285 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 407 | 486 | 569 | 346 | 444 |
Income Taxes Payable | 0 | 0 | 0 | 57 | 34 |
Other Current Liabilities | 0 | 0 | 0 | 51 | 103 |
Total Current Liabilities | 1,079 | 975 | 1,517 | 615 | 951 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 38 | 39 | 23 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 922 | 1,472 | 1,094 | 1,880 | 1,421 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 306 | 375 | 401 | 580 | 303 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,307 | 2,821 | 3,050 | 3,115 | 2,699 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 3 | 3 | 3 | 3 |
Capital Surplus | 1,915 | 1,868 | 1,819 | 1,834 | 1,777 |
Retained Earnings | 2,457 | 2,160 | 1,792 | 1,323 | 1,178 |
Other Equity | -434 | -404 | -327 | -244 | -310 |
Treasury Stock | 133 | 160 | 190 | 118 | 112 |
Total Shareholder's Equity | 3,808 | 3,467 | 3,097 | 2,798 | 2,537 |
Total Liabilities & Shareholder's Equity | 6,115 | 6,288 | 6,147 | 5,913 | 5,236 |
Total Common Equity | 3,808 | 3,467 | 3,097 | 2,798 | 2,537 |
Shares Outstanding | 228.20 | 220.80 | 221.10 | 221.10 | 220.90 |
Book Value Per Share | 16.69 | 15.70 | 14.01 | 12.65 | 11.48 |
Fiscal Year End for QIAGEN NV falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 890 | 893 | 1,058 | 1,016 | 1,332 |
Receivables | 355 | 344 | 382 | 327 | 313 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 322 | 402 | 398 | 399 | 392 |
Other Current Assets | 262 | 252 | 310 | 221 | 275 |
Total Current Assets | 1,830 | 1,891 | 2,148 | 1,962 | 2,311 |
Net Property & Equipment | 718 | 763 | 765 | 706 | 707 |
Investments & Advances | 9 | 7 | 3 | 63 | 98 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 2,795 | 2,951 | 3,003 | 2,977 | 3,027 |
Deposits & Other Assets | 233 | 195 | 197 | 198 | 205 |
Total Assets | 5,585 | 5,806 | 6,115 | 5,907 | 6,347 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 76 | 75 | 84 | 77 | 84 |
Current Portion Long-Term Debt | 493 | 591 | 588 | 101 | 500 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 466 | 359 | 407 | 347 | 394 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 1,035 | 1,025 | 1,079 | 524 | 978 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 909 | 913 | 922 | 1,382 | 1,388 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 236 | 306 | 306 | 357 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,179 | 2,206 | 2,307 | 2,213 | 2,724 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 3 | 3 | 3 | 3 |
Capital Surplus | 1,646 | 1,636 | 1,915 | 1,903 | 1,890 |
Retained Earnings | 2,265 | 2,486 | 2,457 | 2,361 | 2,283 |
Other Equity | -432 | -424 | -434 | -439 | -418 |
Treasury Stock | 77 | 101 | 133 | 134 | 134 |
Total Shareholder's Equity | 3,405 | 3,600 | 3,808 | 3,694 | 3,624 |
Total Liabilities & Shareholder's Equity | 5,585 | 5,806 | 6,115 | 5,907 | 6,347 |
Total Common Equity | 3,405 | 3,600 | 3,808 | 3,694 | 3,624 |
Shares Outstanding | 228.20 | 228.20 | 228.20 | 221.10 | 220.80 |
Book Value Per Share | 14.92 | 15.77 | 16.69 | 16.71 | 16.41 |